Combination Therapies for MF Management
Panel experts comment on the role of combination therapies in MF and debate if these therapies will be the new standard of care.
Stay updated with breaking news from Future Standards. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Panel experts comment on the role of combination therapies in MF and debate if these therapies will be the new standard of care.
Expert oncologists provide insights into how they might manage patients who present with anemia and myelofibrosis in their practice.
Faculty discuss the best strategies to monitor patients who are receiving treatment of MF as well as commenting on when it might be appropriate to switch therapies.
Experts discuss the clinical implications of the MAJIC-PV trial.
Panel experts talk about when to use cytoreductive therapy and which factors influence their treatment selection as well as reviewing how patients with PV are monitored.